Both in Pharmaceuticals
CDT Equity vs Valion Bio
Over the past year CDT returned −98.7% and VBIO returned −70.0%; their daily moves had a correlation of -0.19.
CDT −98.7% VBIO −70.0%Growth of $1, one year, split-adjusted
| Metric | CDT | VBIO |
|---|---|---|
| Price | $0.0830 | $0.6788 |
| Market cap | $64.0K | $602.5K |
| Today | +3.75% | −13.19% |
| 1 month | −94.3% | −76.0% |
| 6 months | −100.0% | — |
| Year to date | −100.0% | — |
| 1 year | −100.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$390.0K | -$5.3M |
| Dividend yield | — | — |
| Volatility (60d) | 992.3% | — |
| Short % of float | 18.8% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).